News

• CRISPR Therapeutics to Participate in Upcoming Investor Conferences
  03/03/2021 / 14:00 - GlobeNewswire
•  
• Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
  03/03/2021 / 14:00 - GlobeNewswire
•  
• Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
  02/26/2021 / 12:00 - GlobeNewswire
•  
• Royalty Pharma Reports Q4 2020 and Full-Year Results
  02/17/2021 / 13:00 - GlobeNewswire
•  
• CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
  02/16/2021 / 22:01 - GlobeNewswire
•  
• Freeline Announces Expansion of Executive Leadership
  02/16/2021 / 13:00 - GlobeNewswire
•  
• Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
  02/09/2021 / 13:30 - GlobeNewswire
•  
• CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day
  02/05/2021 / 14:00 - GlobeNewswire
•  
• Codexis Appoints Dr. Esther Martinborough to its Board of Directors
  02/03/2021 / 22:05 - GlobeNewswire
•  
• Casana Raises $14 Million in Series A Funding Led by General Catalyst for In-home Heart Health Monitoring Device
  02/03/2021 / 14:12 - GlobeNewswire
•  
• CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer
  02/01/2021 / 14:00 - GlobeNewswire
•  
• BrightInsight Names Technology and Healthcare Leaders to Advisory Council
  01/25/2021 / 14:00 - GlobeNewswire
•  
• Carla Poulson Joins Mersana Therapeutics as Chief Human Resources Officer
  01/19/2021 / 14:00 - GlobeNewswire
•  
• Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company
  01/12/2021 / 13:00 - GlobeNewswire
•  
• Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
  12/17/2020 / 14:00 - GlobeNewswire